Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer.

about

Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer.

Item

http://www.wikidata.org/entity/Q38675663

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer.

@en

type

Item

label

Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer.

@en

prefLabel

Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer.

@en

P1476

Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer.

@en

P2093

Brian D Badgwell

http://www.w3.org/2001/XMLSchema#string

Charlotte C Sun

http://www.w3.org/2001/XMLSchema#string

Hui Zhao

http://www.w3.org/2001/XMLSchema#string

Karen H Lu

http://www.w3.org/2001/XMLSchema#string

Larissa A Meyer

http://www.w3.org/2001/XMLSchema#string

Lois M Ramondetta

http://www.w3.org/2001/XMLSchema#string

Rudy S Suidan

http://www.w3.org/2001/XMLSchema#string

Weiguo He

http://www.w3.org/2001/XMLSchema#string

P2860

Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Cancer statistics, 2016

Development of a comorbidity index using physician claims data.

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Use of SEER-Medicare data for measuring cancer surgery.

Estimating health care costs related to cancer treatment from SEER-Medicare data.

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.

Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian cancer.

Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution

P304

1350-1359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/IGC.0000000000000998

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sharon H. Giordano

Diane C Bodurka

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28574929

http://www.w3.org/2001/XMLSchema#string

P932

5862427

http://www.w3.org/2001/XMLSchema#string